Cite
Dosing related effects of zoledronic acid on bone markers and creatinine clearance in patients with multiple myeloma and metastatic breast cancer.
MLA
Søe, Kent, et al. “Dosing Related Effects of Zoledronic Acid on Bone Markers and Creatinine Clearance in Patients with Multiple Myeloma and Metastatic Breast Cancer.” Acta Oncologica, vol. 53, no. 4, Apr. 2014, pp. 547–56. EBSCOhost, https://doi.org/10.3109/0284186X.2013.844358.
APA
Søe, K., Delaiss, J.-M., Jakobsen, E. H., Hansen, C. T., & Plesner, T. (2014). Dosing related effects of zoledronic acid on bone markers and creatinine clearance in patients with multiple myeloma and metastatic breast cancer. Acta Oncologica, 53(4), 547–556. https://doi.org/10.3109/0284186X.2013.844358
Chicago
Søe, Kent, Jean-Marie Delaiss, Erik H. Jakobsen, Charlotte T. Hansen, and Torben Plesner. 2014. “Dosing Related Effects of Zoledronic Acid on Bone Markers and Creatinine Clearance in Patients with Multiple Myeloma and Metastatic Breast Cancer.” Acta Oncologica 53 (4): 547–56. doi:10.3109/0284186X.2013.844358.